146 related articles for article (PubMed ID: 31511187)
1. Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer.
Rossi SH; Blick C; Nathan P; Nicol D; Stewart GD; Wilson ECF
Value Health; 2019 Sep; 22(9):981-987. PubMed ID: 31511187
[TBL] [Abstract][Full Text] [Related]
2. A comparison of two methods for expert elicitation in health technology assessments.
Grigore B; Peters J; Hyde C; Stein K
BMC Med Res Methodol; 2016 Jul; 16():85. PubMed ID: 27456844
[TBL] [Abstract][Full Text] [Related]
3. EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.
Grigore B; Peters J; Hyde C; Stein K
BMC Med Inform Decis Mak; 2017 Sep; 17(1):131. PubMed ID: 28870196
[TBL] [Abstract][Full Text] [Related]
4. Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma.
Wilson ECF; Usher-Smith JA; Emery J; Corrie PG; Walter FM
Value Health; 2018 Jun; 21(6):669-676. PubMed ID: 29909871
[TBL] [Abstract][Full Text] [Related]
5. Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.
Bojke L; Grigore B; Jankovic D; Peters J; Soares M; Stein K
Pharmacoeconomics; 2017 Sep; 35(9):867-877. PubMed ID: 28616775
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and screening for renal cancer.
Rossi SH; Klatte T; Usher-Smith J; Stewart GD
World J Urol; 2018 Sep; 36(9):1341-1353. PubMed ID: 29610964
[TBL] [Abstract][Full Text] [Related]
7. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
Diana P; Klatte T; Amparore D; Bertolo R; Carbonara U; Erdem S; Ingels A; Kara O; Marandino L; Marchioni M; Muselaers S; Pavan N; Pecoraro A; Pecoraro A; Roussel E; Campi R;
World J Urol; 2023 Apr; 41(4):929-940. PubMed ID: 35362747
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
9. Radiology in the diagnosis and staging of renal cell carcinoma.
Zagoria RJ; Dyer RB; Wolfman NT; Hinn GC; Chen YM
Crit Rev Diagn Imaging; 1990; 31(1):81-115. PubMed ID: 2288659
[TBL] [Abstract][Full Text] [Related]
10. Current evidence on screening for renal cancer.
Usher-Smith J; Simmons RK; Rossi SH; Stewart GD
Nat Rev Urol; 2020 Nov; 17(11):637-642. PubMed ID: 32860009
[TBL] [Abstract][Full Text] [Related]
11. COMPARISON OF METHODS FOR ESTIMATING CONTEMPORARY COSTS: AN APPLICATION TO LIVER TRANSPLANTATION IN THE UNITED KINGDOM.
Singh J; Longworth L
Int J Technol Assess Health Care; 2017 Jan; 33(6):620-628. PubMed ID: 28934994
[TBL] [Abstract][Full Text] [Related]
12. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
13. Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect.
Jankovic D; Payne K; Kanaan M; Bojke L
Int J Technol Assess Health Care; 2022 Feb; 38(1):e21. PubMed ID: 35177145
[TBL] [Abstract][Full Text] [Related]
14. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.
Vasudev NS; Wilson M; Stewart GD; Adeyoju A; Cartledge J; Kimuli M; Datta S; Hanbury D; Hrouda D; Oades G; Patel P; Soomro N; Sullivan M; Webster J; Selby PJ; Banks RE
BMJ Open; 2020 May; 10(5):e035938. PubMed ID: 32398335
[TBL] [Abstract][Full Text] [Related]
15. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review.
Silva-Illanes N; Espinoza M
Value Health; 2018 Jul; 21(7):858-873. PubMed ID: 30005759
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation.
Kearns B; Chilcott J; Whyte S; Preston L; Sadler S
BMC Med; 2016 Dec; 14(1):200. PubMed ID: 27919292
[TBL] [Abstract][Full Text] [Related]
17. Use of Expert Judgement Across NICE Guidance-Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation.
Peel A; Jenks M; Choudhury M; Lovett R; Rejon-Parrilla JC; Sims A; Craig J
Appl Health Econ Health Policy; 2018 Dec; 16(6):819-836. PubMed ID: 30073485
[TBL] [Abstract][Full Text] [Related]
18. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
19. Staging of renal cell carcinoma: past, present, and future.
Nguyen CT; Campbell SC
Clin Genitourin Cancer; 2006 Dec; 5(3):190-7. PubMed ID: 17239272
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
